{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:15:03Z","timestamp":1791389703145,"version":"4.3.3"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005984","name":"Dr. Miriam and Sheldon G. Adelson Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005984","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.addr.2020.02.002","type":"journal-article","created":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T13:45:14Z","timestamp":1582292714000},"page":"65-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":96,"special_numbering":"C","title":["Topical treatment strategies to manipulate human skin pigmentation"],"prefix":"10.1016","volume":"153","author":[{"given":"Inbal","family":"Rachmin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Ostrowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing Yu","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2020.02.002_bb0005","first-page":"481","article-title":"The epidermal melanin unit system","volume":"147","author":"Fitzpatrick","year":"1963","journal-title":"Dermatol. Wochenschr."},{"key":"10.1016\/j.addr.2020.02.002_bb0010","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1152\/physrev.00044.2003","article-title":"Melanin pigmentation in mammalian skin and its hormonal regulation","volume":"84","author":"Slominski","year":"2004","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.addr.2020.02.002_bb0015","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nature05660","article-title":"Melanocyte biology and skin pigmentation","volume":"445","author":"Lin","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.addr.2020.02.002_bb0020","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/ng1195-328","article-title":"Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans","volume":"11","author":"Valverde","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.addr.2020.02.002_bb0025","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0092-8674(93)90572-8","article-title":"Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function","volume":"72","author":"Robbins","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.addr.2020.02.002_bb0030","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/genetics\/151.4.1547","article-title":"High polymorphism at the human melanocortin 1 receptor locus","volume":"151","author":"Rana","year":"1999","journal-title":"Genetics"},{"key":"10.1016\/j.addr.2020.02.002_bb0035","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nature05098","article-title":"Topical drug rescue strategy and skin protection based on the role of Mc1r in UV-induced tanning","volume":"443","author":"D'Orazio","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.addr.2020.02.002_bb0040","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.cell.2006.12.045","article-title":"Central role of p53 in the suntan response and pathologic hyperpigmentation","volume":"128","author":"Cui","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.addr.2020.02.002_bb0045","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1083\/jcb.142.3.827","article-title":"Microphthalmia gene product as a signal transducer in cAMP-induced differentiation of melanocytes","volume":"142","author":"Bertolotto","year":"1998","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.addr.2020.02.002_bb0050","doi-asserted-by":"crossref","first-page":"33042","DOI":"10.1074\/jbc.273.49.33042","article-title":"alpha-Melanocyte-stimulating hormone signaling regulates expression of microphthalmia, a gene deficient in Waardenburg syndrome","volume":"273","author":"Price","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2020.02.002_bb0055","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1600-0749.1995.tb00664.x","article-title":"Eumelanin and phaeomelanin contents of human epidermis and cultured melanocytes","volume":"8","author":"Hunt","year":"1995","journal-title":"Pigment Cell Res."},{"key":"10.1016\/j.addr.2020.02.002_bb0060","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1093\/emboj\/16.12.3544","article-title":"Modulation of murine melanocyte function in vitro by agouti signal protein","volume":"16","author":"Sakai","year":"1997","journal-title":"EMBO J."},{"key":"10.1016\/j.addr.2020.02.002_bb0065","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1751-1097.2007.00226.x","article-title":"The protective role of melanin against UV damage in human skin","volume":"84","author":"Brenner","year":"2008","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.addr.2020.02.002_bb0070","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/pcmr.12121","article-title":"Melanins and melanogenesis: methods, standards, protocols","volume":"26","author":"d'Ischia","year":"2013","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.addr.2020.02.002_bb0075","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/nature11624","article-title":"An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair\/fair skin background","volume":"491","author":"Mitra","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.addr.2020.02.002_bb0080","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1096\/fj.06-5725fje","article-title":"Human skin responses to UV radiation: pigment in the upper epidermis protects against DNA damage in the lower epidermis and facilitates apoptosis","volume":"20","author":"Yamaguchi","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.addr.2020.02.002_bb0085","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/1097-0142(19950115)75:2+<667::AID-CNCR2820751409>3.0.CO;2-I","article-title":"Skin cancer in African Americans","volume":"75","author":"Halder","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.addr.2020.02.002_bb0090","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/pcmr.12257","article-title":"MC1R, the cAMP pathway, and the response to solar UV: extending the horizon beyond pigmentation","volume":"27","author":"Garcia-Borron","year":"2014","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.addr.2020.02.002_bb0095","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1146\/annurev.genet.37.110801.143233","article-title":"Genetics of hair and skin color","volume":"37","author":"Rees","year":"2003","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.addr.2020.02.002_bb0100","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1600-0749.2005.00233.x","article-title":"Eumelanin and pheomelanin concentrations in human epidermis before and after UVB irradiation","volume":"18","author":"Hennessy","year":"2005","journal-title":"Pigment Cell Res."},{"key":"10.1016\/j.addr.2020.02.002_bb0105","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.peptides.2005.01.029","article-title":"Melanocortin peptide therapeutics: historical milestones, clinical studies and commercialization","volume":"27","author":"Hadley","year":"2006","journal-title":"Peptides"},{"key":"10.1016\/j.addr.2020.02.002_bb0110","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1056\/NEJMoa1411481","article-title":"Afamelanotide for erythropoietic protoporphyria","volume":"373","author":"Langendonk","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.addr.2020.02.002_bb0115","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1365-2133.2009.09362.x","article-title":"Eruptive melanocytic naevi following melanotan injection","volume":"161","author":"Cousen","year":"2009","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.addr.2020.02.002_bb0120","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1440-0960.2012.00915.x","article-title":"Melanotan-associated melanoma in situ","volume":"53","author":"Ong","year":"2012","journal-title":"Aust. J. Dermatol."},{"key":"10.1016\/j.addr.2020.02.002_bb0125","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2133.2010.09891.x","article-title":"Melanotropic peptides: more than just \u2018Barbie drugs\u2019 and \u2018sun-tan jabs\u2019?","volume":"163","author":"Langan","year":"2010","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.addr.2020.02.002_bb0130","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1073\/pnas.78.6.3363","article-title":"Forskolin: unique diterpene activator of adenylate cyclase in membranes and in intact cells","volume":"78","author":"Seamon","year":"1981","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2020.02.002_bb0135","first-page":"201","article-title":"Forskolin: a unique diterpene activator of cyclic AMP-generating systems","volume":"7","author":"Seamon","year":"1981","journal-title":"J. Cyclic Nucl. Res."},{"key":"10.1016\/j.addr.2020.02.002_bb0140","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1084\/jem.187.10.1565","article-title":"Murine cutaneous mastocytosis and epidermal melanocytosis induced by keratinocyte expression of transgenic stem cell factor","volume":"187","author":"Kunisada","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.addr.2020.02.002_bb0145","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.0022-202X.2004.22710.x","article-title":"XPA gene-deficient, SCF-transgenic mice with epidermal melanin are resistant to UV-induced carcinogenesis","volume":"123","author":"Yamazaki","year":"2004","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.addr.2020.02.002_bb0150","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1101\/gad.1937710","article-title":"Control of melanocyte differentiation by a MITF-PDE4D3 homeostatic circuit","volume":"24","author":"Khaled","year":"2010","journal-title":"Genes Dev."},{"key":"10.1016\/j.addr.2020.02.002_bb0155","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/j.1755-148X.2010.00760.x","article-title":"Downregulation of SIK2 expression promotes the melanogenic program in mice","volume":"23","author":"Horike","year":"2010","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.addr.2020.02.002_bb0160","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nrm3072","article-title":"CREB and the CRTC co-activators: sensors for hormonal and metabolic signals","volume":"12","author":"Altarejos","year":"2011","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.addr.2020.02.002_bb0165","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1042\/BJ20111932","article-title":"The AMPK-related kinase SIK2 is regulated by cAMP via phosphorylation at Ser358 in adipocytes","volume":"444","author":"Henriksson","year":"2012","journal-title":"Biochem. J."},{"key":"10.1016\/j.addr.2020.02.002_bb0170","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/j.celrep.2017.05.042","article-title":"A UV-independent topical small-molecule approach for melanin production in human skin","volume":"19","author":"Mujahid","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.addr.2020.02.002_bb0175","doi-asserted-by":"crossref","first-page":"4535","DOI":"10.1038\/ncomms5535","article-title":"The LKB1-salt-inducible kinase pathway functions as a key gluconeogenic suppressor in the liver","volume":"5","author":"Patel","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2020.02.002_bb0180","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.abb.2014.07.019","article-title":"The roles of microphthalmia-associated transcription factor and pigmentation in melanoma","volume":"563","author":"Hsiao","year":"2014","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.addr.2020.02.002_bb0185","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1517\/14728222.2016.1101452","article-title":"The diverse oncogenic and tumor suppressor roles of salt-inducible kinase (SIK) in cancer","volume":"20","author":"Du","year":"2016","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.addr.2020.02.002_bb0190","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/ics.12468","article-title":"Exploring pathways for sustained melanogenesis in facial melasma: an immunofluorescence study","volume":"40","author":"Esposito","year":"2018","journal-title":"Int. J. Cosmet. Sci."},{"key":"10.1016\/j.addr.2020.02.002_bb0195","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1046\/j.1365-2133.2002.4513_3.x","article-title":"Increased expression of alpha-melanocyte-stimulating hormone in the lesional skin of melasma","volume":"146","author":"Im","year":"2002","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.addr.2020.02.002_bb0200","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/DAD.0b013e3181cd4396","article-title":"Morphologic changes and the expression of alpha-melanocyte stimulating hormone and melanocortin-1 receptor in melasma lesions: a comparative study","volume":"32","author":"Miot","year":"2010","journal-title":"Am. J. Dermatopathol."},{"key":"10.1016\/j.addr.2020.02.002_bb0205","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/jidsymp.2008.7","article-title":"Latest insights into skin hyperpigmentation","volume":"13","author":"Ortonne","year":"2008","journal-title":"J. Investig. Dermatol. Symp. Proc."},{"key":"10.1016\/j.addr.2020.02.002_bb0210","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/cup.12849","article-title":"Two histopathological patterns of postinflammatory hyperpigmentation: epidermal and dermal","volume":"44","author":"Park","year":"2017","journal-title":"J. Cutan. Pathol."},{"key":"10.1016\/j.addr.2020.02.002_bb0215","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1084\/jem.20171608","article-title":"Unveiling skin macrophage dynamics explains both tattoo persistence and strenuous removal","volume":"215","author":"Baranska","year":"2018","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.addr.2020.02.002_bb0220","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0190-9622(88)70217-0","article-title":"Melanophages in inflammatory skin disease demonstrate the surface phenotype of OKM5+ antigen-presenting cells and activated macrophages","volume":"19","author":"Weiss","year":"1988","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.addr.2020.02.002_bb0225","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1001\/archderm.142.9.1250","article-title":"Dermoscopic color perspective","volume":"142","author":"Weismann","year":"2006","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.addr.2020.02.002_bb0230","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/pcmr.12232","article-title":"Sun-induced freckling: ephelides and solar lentigines","volume":"27","author":"Praetorius","year":"2014","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.addr.2020.02.002_bb0235","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/1523-1747.ep12581580","article-title":"Effects of aging and chronic sun exposure on melanocytes in human skin","volume":"73","author":"Gilchrest","year":"1979","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.addr.2020.02.002_bb0240","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/009841098158863","article-title":"Human in vivo and in vitro hydroquinone topical bioavailability, metabolism, and disposition","volume":"54","author":"Wester","year":"1998","journal-title":"J. Toxicol. Environ. Health A"},{"key":"10.1016\/j.addr.2020.02.002_bb0245","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0304-4165(91)90186-K","article-title":"Mechanism of inhibition of melanogenesis by hydroquinone","volume":"1073","author":"Palumbo","year":"1991","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.addr.2020.02.002_bb0250","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/BF02979054","article-title":"Relationship between tyrosinase inhibitory action and oxidation-reduction potential of cosmetic whitening ingredients and phenol derivatives","volume":"22","author":"Sakuma","year":"1999","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.addr.2020.02.002_bb0255","doi-asserted-by":"crossref","first-page":"4364","DOI":"10.1016\/j.bmc.2012.05.041","article-title":"The influence of hydroquinone on tyrosinase kinetics","volume":"20","author":"Stratford","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.addr.2020.02.002_bb0260","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1600-0749.1988.tb00140.x","article-title":"Selective cytotoxicity of hydroquinone for melanocyte-derived cells is mediated by tyrosinase activity but independent of melanin content","volume":"1","author":"Smith","year":"1988","journal-title":"Pigment Cell Res."},{"key":"10.1016\/j.addr.2020.02.002_bb0265","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/1523-1747.ep12701679","article-title":"Mechanism of depigmentation by hydroquinone","volume":"62","author":"Jimbow","year":"1974","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.addr.2020.02.002_bb0270","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.jaad.2006.02.009","article-title":"The treatment of melasma: a review of clinical trials","volume":"55","author":"Gupta","year":"2006","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.addr.2020.02.002_bb0275","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ejpb.2012.03.006","article-title":"The co-drug of conjugated hydroquinone and azelaic acid to enhance topical skin targeting and decrease penetration through the skin","volume":"81","author":"Hsieh","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2020.02.002_bb0280","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jdermsci.2014.08.013","article-title":"Hydroquinone-salicylic acid conjugates as novel anti-melasma actives show superior skin targeting compared to the parent drugs","volume":"76","author":"Hsieh","year":"2014","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.addr.2020.02.002_bb0285","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.2174\/15672050113109990202","article-title":"Co-drug strategy for promoting skin targeting and minimizing the transdermal diffusion of hydroquinone and tranexamic acid","volume":"20","author":"Hsieh","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.addr.2020.02.002_bb0290","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0022-3565(25)12357-4","article-title":"Arbutin: mechanism of its depigmenting action in human melanocyte culture","volume":"276","author":"Maeda","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.addr.2020.02.002_bb0295","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1111\/j.1365-2133.2008.08864.x","article-title":"Mechanism of tyrosinase inhibition by deoxyArbutin and its second-generation derivatives","volume":"159","author":"Chawla","year":"2008","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.addr.2020.02.002_bb0300","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1600-0749.1998.tb00705.x","article-title":"Arbutin increases the pigmentation of cultured human melanocytes through mechanisms other than the induction of tyrosinase activity","volume":"11","author":"Nakajima","year":"1998","journal-title":"Pigment Cell Res."},{"key":"10.1016\/j.addr.2020.02.002_bb0305","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/0738-081X(89)90061-8","article-title":"Azelaic acid therapy in disorders of pigmentation","volume":"7","author":"Breathnach","year":"1989","journal-title":"Clin. Dermatol."},{"key":"10.1016\/j.addr.2020.02.002_bb0310","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/BF00372617","article-title":"A possible mechanism of action for azelaic acid in the human epidermis","volume":"282","author":"Schallreuter","year":"1990","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.addr.2020.02.002_bb0315","first-page":"36","article-title":"Melanin hyperpigmentation of skin: melasma, topical treatment with azelaic acid, and other therapies","volume":"57","author":"Breathnach","year":"1996","journal-title":"Cutis"},{"key":"10.1016\/j.addr.2020.02.002_bb0320","first-page":"58","article-title":"Double-blind comparison of azelaic acid and hydroquinone in the treatment of melasma","volume":"143","author":"Verallo-Rowell","year":"1989","journal-title":"Acta Derm. Venereol. Suppl. (Stockh.)"},{"key":"10.1016\/j.addr.2020.02.002_bb0325","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/j.1365-4362.1991.tb04362.x","article-title":"The treatment of melasma. 20% azelaic acid versus 4% hydroquinone cream","volume":"30","author":"Balina","year":"1991","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.addr.2020.02.002_bb0330","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.7150\/thno.24385","article-title":"Alpha-Viniferin improves facial hyperpigmentation via accelerating feedback termination of cAMP\/PKA-signaled phosphorylation circuit in facultative Melanogenesis","volume":"8","author":"Yun","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.addr.2020.02.002_bb0335","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1467-2494.1997.tb00193.x","article-title":"Biological screening of 100 plant extracts for cosmetic use (I): inhibitory activities of tyrosinase and DOPA auto-oxidation","volume":"19","author":"Lee","year":"1997","journal-title":"Int. J. Cosmet. Sci."},{"key":"10.1016\/j.addr.2020.02.002_bb0340","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1016\/j.bmcl.2017.06.011","article-title":"Synthesis and biological evaluation of caffeic acid derivatives as potent inhibitors of alpha-MSH-stimulated melanogenesis","volume":"27","author":"Jo","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.addr.2020.02.002_bb0345","doi-asserted-by":"crossref","first-page":"646","DOI":"10.7150\/thno.30276","article-title":"Nuclear entry of CRTC1 as druggable target of acquired pigmentary disorder","volume":"9","author":"Yun","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.addr.2020.02.002_bb0350","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jaad.2017.09.053","article-title":"Randomized, placebo-controlled, double-blind study of oral tranexamic acid in the treatment of moderate-to-severe melasma","volume":"78","author":"Del Rosario","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.addr.2020.02.002_bb0355","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jaad.2016.03.001","article-title":"Oral tranexamic acid (TA) in the treatment of melasma: a retrospective analysis","volume":"75","author":"Lee","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.addr.2020.02.002_bb0360","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/jocd.12291","volume":"16","author":"Lajevardi","year":"2017","journal-title":"J. Cosmet. Dermatol."},{"key":"10.1016\/j.addr.2020.02.002_bb0365","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/nature07163","article-title":"Cell-specific ATP7A transport sustains copper-dependent tyrosinase activity in melanosomes","volume":"454","author":"Setty","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.addr.2020.02.002_bb0370","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s007750050370","article-title":"Inhibition of the catecholase activity of biomimetic dinuclear copper complexes by kojic acid","volume":"5","author":"Battaini","year":"2000","journal-title":"J. Biol. Inorg. Chem."},{"key":"10.1016\/j.addr.2020.02.002_bb0375","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1046\/j.1524-4725.1999.08236.x","article-title":"Treatment of melasma using kojic acid in a gel containing hydroquinone and glycolic acid","volume":"25","author":"Lim","year":"1999","journal-title":"Dermatol. Surg."},{"key":"10.1016\/j.addr.2020.02.002_bb0380","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/0190-9622(90)70265-J","article-title":"Sustained improvement with prolonged topical tretinoin (retinoic acid) for photoaged skin","volume":"23","author":"Ellis","year":"1990","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.addr.2020.02.002_bb0385","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1001\/jama.1988.03720040019020","article-title":"Topical tretinoin improves photoaged skin. A double-blind vehicle-controlled study","volume":"259","author":"Weiss","year":"1988","journal-title":"JAMA"},{"key":"10.1016\/j.addr.2020.02.002_bb0390","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1001\/archderm.1991.01680040067005","article-title":"Topical tretinoin for treatment of photodamaged skin. A multicenter study","volume":"127","author":"Weinstein","year":"1991","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.addr.2020.02.002_bb0395","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/pcmr.12726","article-title":"MITF and UV responses in skin: from pigmentation to addiction","volume":"32","author":"Nguyen","year":"2019","journal-title":"Pigment Cell Melanoma Res."}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X20300089?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X20300089?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T04:50:54Z","timestamp":1759207854000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X20300089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":79,"alternative-id":["S0169409X20300089"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2020.02.002","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topical treatment strategies to manipulate human skin pigmentation","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2020.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}